These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 555571)

  • 1. Heparin: biochemistry, therapy, and laboratory monitoring.
    Triplett DA
    Ther Drug Monit; 1979; 1(2):173-97. PubMed ID: 555571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of heparin therapy.
    Gervin AS
    Surg Gynecol Obstet; 1975 May; 140(5):789-96. PubMed ID: 1170648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antithrombin III. Physiologic, physiopathologic and laboratory aspects].
    de Sousa JC; Ferreira R; Carriço F; Nunes V; Geraldes MJ; Parreira F; Ribeiro C
    Rev Port Cardiol; 1991 Sep; 10(9):693-9. PubMed ID: 1747261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical relevance of antithrombin III.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):276-87. PubMed ID: 6758119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulable states: new knowledge about old problems.
    Moake JL
    Hosp Pract (Off Ed); 1991 Mar; 26(3A):31-42. PubMed ID: 1826007
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exotic snakebite in an urban setting: heparin therapy of disseminated intravascular coagulation in a patient bitten by a saw-scaled viper (Echis carinatus).
    Christy NP; Weiss HJ; Phillips LL; Phillips GB; Hopewell W
    Trans Am Clin Climatol Assoc; 1973; 84():37-48. PubMed ID: 4729257
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological supervision of heparin therapy].
    Forestier F
    Phlebologie; 1975; 28(1):19-22. PubMed ID: 1202526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin monitoring in the coronary care unit after percutaneous transluminal coronary angioplasty.
    Varah N; Smith J; Baugh RF
    Heart Lung; 1990 May; 19(3):265-70. PubMed ID: 2341265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.